RUNX2 and bone inflammation disease: These signals promote osteoclast differentiation via the RANKL pathway and inhibit the osteoblast activity via the Wnt pathway and the transcription factor Runx2, causing inflammatory osteolysis and promoting the development and progression of inflammatory bone disease.